ArticleJournal of market access & health policy2019

Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective.

Pierre Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.